Prooxidant properties of ascorbic acid in the nigrostriatal dopaminergic system of C57BL/6 mice

Toxicology

Volumn 294, Issue 1, 2012, Pages 1-8

  Kang, Min Jeong ^a   Lee, Sang Sun ^a   Koh, Hyun Chul ^a  

^a Hanyang University   (South Korea)

Author keywords

Ascorbic acid; Dopamine; Glutathione; Striatum; Substantia nigra pars compacta

Indexed keywords

ASCORBIC ACID; DOPAMINE; GLUTATHIONE; TYROSINE 3 MONOOXYGENASE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SUBSTANTIA NIGRA PARS COMPACTA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ASCORBIC ACID; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; GLUTATHIONE; MALE; MICE; MICE, INBRED C57BL; OXIDANTS; OXIDATION-REDUCTION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 84862806180     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.01.007     Document Type: Article

References (51)

1. Antkiewicz-Michaluk L., Michaluk J., Mokrosz M., Romanska I., Lorenc-Koci E., Ohta S., Vetulani J. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4,-tetrahydroisoquinolines with similar antidopaminergic properties. J. Neurochem. 2001, 78:100-108.
2. Agarwal R., Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem. Res. 1999, 24:1507-1514.
3. Carr A., Frei B. Does vitamin C act as a pro-oxidant under physiological conditions. FASEB J. 1999, 13:1007-1024.
4. Chen Q., Espey M.G., Sun A.Y., Lee J.H., Krishna M.C., Shacter E., Choyke P.L., Pooput C., Kirk K.L., Buettner G.R., Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8749-8754.
5. Chio H.Y., Song J.H., Park D.K., Ross G.M. The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics. Neurosci. Lett. 2000, 296:81-84.
6. Cohen G. The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J. Neural Transm. 1983, 19:89-103.
7. DeMaria J.E., Lerant A.A., Freeman M.E. Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res. 1999, 837:236-241.
8. Desole M.S., Esposito G., Fresu L., Migheli R., Enrico P., Miele M., De Natale G., Miele E. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat. Neurosci. Lett. 1993, 161:121-123.
9. Desole M.S., Miele M., Enrico P., Esposito G., Fresu L., De Natale G., Miele E. Investigations into the relationship between the dopaminergic system and ascorbic acid in rat striatum. Neurosci. Lett. 1991, 127:34-38.
10. Duarte T.L., Lunec J. Review: when is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radic. Res. 2005, 39:671-686.
11. Fornstedt B., Carlsson A. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. J. Neurochem. 1991, 56:407-414.
12. Gabbay M., Tauber M., Porat S., Simantov R. Selective role of glutathione in protecting human neuronal cells form dopamine-induced apoptosis. Neuropharmacology 1996, 35:571-578.
13. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic. Res. 1996, 25:439-454.
14. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59:1609-1623.
15. Hara S., Endo S.T., Kuriiwa F., Kano S. Different effects of paraquat on microsomal lipid peroxidation in mouse brain, lung and liver. Pharmacol. Toxicol. 1991, 68:260-265.
16. Hara S., Mizukami H., Kuriiwa F., Endo T. Hydroxyl radical generation dependent on extracellular ascorbate in rat striatum, as determined by microdialysis. Toxicology 2009, 258:10-16.
17. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1956-1961.
18. Harrison F.E., May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009, 46:719-730.
19. Hornig D. Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann. N.Y. Acad. Sci. 1975, 258:103-118.
20. Jain A., Martensson J., Stole E., Auld P.A., Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:1913-1917.
21. Jiang Y., Pei L., Li S., Wang M., Liu F. Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells. Synapse 2008, 62:797-803.
22. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.Q., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R.A., Bush A.I., Andersen J.K. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003, 37:899-909.
23. Langston J.W., Langston E.B., Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol. Scand. Suppl. 1984, 100:49-54.
24. Liou H.H., Chen R.C., Chen T.H., Tsai Y.F., Tsai M.C. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo. Toxicol. Appl. Pharmacol. 2001, 172:37-43.
25. Mori A., Ohashi S., Nakai M., Moriizumi T., Mitsumoto Y. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Neurosci. Res. 2005, 51:265-274.
26. Pastore A., Federici G., Bertini E., Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 2003, 333:19-39.
27. Paxinos G., Frankin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, New York.
28. Park S.W., Lee S.M. Antioxidant and prooxidant properties of ascorbic acid on hepatic dysfunction induced by cold ischemia/reperfusion. Eur. J. Pharmacol. 2008, 580:401-406.
29. Pifl C., Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem. Int. 2006, 49:519-524.
30. Pileblad E., Slivka A., Bratvold D., Cohen G. Studies on the autoxidation of dopamine: interaction with ascorbate. Arch. Biochem. Biophys. 1988, 333:447-452.
31. Rabinovic A.D., Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 1998, 71:2071-2078.
32. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995, 9:526-533.
33. Rebec G.V., Pierce R.C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 1994, 43:537-565.
34. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000, 23:209-216.
35. Riederer P., Jellinger K. Neurochemical insights into monoamine oxidase inhibitor, with special reference to deprenyl (selegiline). Acta Neurol. Scand. Suppl. 1983, 95:43-55.
36. Saponjic R.M., Mueller K., Krug D., Kunko P.M. The effects of haloperidol, scopolamine, and MK-801 on amphetamine-induced increases in ascorbic and uric acid as determined by voltammetry in vivo. Pharmacol. Biochem. Behav. 1994, 48:161-168.
37. Schulz J.B., Lindenau J., Seyfried J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 2000, 267:4904-4911.
38. Shepherd K.R., Lee E.S., Schmued L., Jiao Y., Ali S.F., Oriaku E.T., Lamango N.S., Soliman K.F.A., Charlton C.G. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Pharmacol. Biochem. Behav. 2006, 83:349-359.
39. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 1992, 142:128-130.
40. Song J.H., Shin S.H., Ross G.M. Prooxidant effects of ascorbate in rat brain slices. J. Neurosci. Res. 1999, 58:328-336.
41. Song J.H., Shin S.H., Ross G.M. Oxidative stress induced by ascorbate causes neuronal damage in an in vitro system. Brain Res. 2001, 895:66-72.
42. Speiser Z., Levy R., Cohen S. Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. J. Neural Transm. Suppl. 1998, 52:287-300.
43. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:1389-1400.
44. Stern G. Neuroprotection by selegiline and other MAO inhibitors. J. Neural Transm. Suppl. 1998, 52:99-107.
45. Velez-Pardo C., Jimenez Del Rio M., Verschueren H., Ebinger G., Vauquelin G. Dopamine and iron induce apoptosis in PC12 cells. Pharmacol. Toxicol. 1997, 80:76-86.
46. Waddington J.L., Crow T.J. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling. Brain Res. 1979, 161:371-376.
47. Wagner G.C., Carelli R.M., Jarvis M.F. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion. Neuropharmacology 1986, 25:559-561.
48. Westerink B.H., Spaan S.J. Simultaneous determination of the formation rats of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas. Brain Res. 1982, 252:239-425.
49. Winterbourn C.C., Metadiewa D. The reaction of superoxide with reduced glutathione. Arch. Biochem. Biophys. 1994, 314:284-290.
50. Wolfarth S., Coelle E.F., Osborne N.N., Sontag K.H. Evidence for a neurotoxic effect of ascorbic acid after an intranigral injection in the cat. Neurosci. Lett. 1977, 6:183-186.
51. Zhang S.M., Hernán M.A., Chen H., Spiegelman D., Willett W.C., Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 2002, 59:1161-1169.